IO

Zero ASIC Democratizing Chip Making

Retrieved on: 
Tuesday, October 17, 2023
Silicon, 3D, RTL, ASIC, Chiplet, Gamer, COTS, 2D, IO, Robotics, Field-programmable gate array, UCIe, Catalog, Software, SOC, Application-specific integrated circuit, Semiconductor, Cryptocurrency

CAMBRIDGE, Ma., Oct. 17, 2023 /PRNewswire/ -- Zero ASIC, a semiconductor startup, today announced early access to its one-of-a-kind ChipMaker platform, demonstrating a number of world firsts:

Key Points: 
  • Our mission at Zero ASIC is to make ordering an ASIC as easy as ordering catalog parts from an electronics distributor."
  • Zero ASIC has delivered on the chiplet vision by by creating a platform that enables automated design, validation, and assembly of System-in-Packages from a catalog of known good chiplets.
  • To address these problems, Zero ASIC has developed eFabric, an active grid-like 3D interposer that improves die-to-die communication efficiency and composability.
  • Zero ASIC will be showing live demonstrations of the ChipMaker platform at the Open Compute Platform Summit (Open Chiplet Economy Center) October 17-19, in San Jose, CA.

QuestionPro Announces Fall XDay North America Lineup

Retrieved on: 
Monday, October 9, 2023
Breakout (1975 film), Ford, XDAIS algorithms, Harmonization, The Coca-Cola Company, LendingTree, Dell, Personality, Good Housekeeping, Heinz, Success, Intel, Wendy's, Get It Together, Atlanta Hotel, Nielsen, IO, Frame, Central Time Zone, GE, Colgate-Palmolive, Adobe, Pfizer, Life, José Rijo, The Walt Disney Company, New Balance

AUSTIN, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) -- QuestionPro , a global leader in online survey and research services today announced the agenda and speaker lineup for its annual customer event, XDay 2023 North America .

Key Points: 
  • AUSTIN, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) -- QuestionPro , a global leader in online survey and research services today announced the agenda and speaker lineup for its annual customer event, XDay 2023 North America .
  • The event takes place October 26, 2023 from 9:00 a.m. – 4:30 p.m. (U.S. Central Time) at the Thompson Hotel in Austin.
  • He will unveil exciting new products and feature updates across QuestionPro product lines and set the stage for a day of innovation and inspiration.
  • QuestionPro executives will also lead breakout sessions on best practices for leveraging the QuestionPro platform to: Empower change in an organization; Harmonize efforts with Experience Mapping; preview the road ahead for new features.

Global 3D TSV Devices Strategic Market Report 2023-2030: Ongoing Proliferation of Cloud-Based Applications to Encourage Adoption of 3D TSV Devices

Retrieved on: 
Monday, October 9, 2023
Cloud, COVID-19, Information Communications Technology education in the Philippines, MEMS, Real, Communication, Developed country, Comparison, DRAM, Osat, Transformation, ASE Group, Development, Defense, Broadcom Inc., TSV, Growth, Disruption, IO, Consumer electronics, Information and communications technology, Amkor Technology, Mems, VS, Access, Memory, Total cost, Industrial internet of things, IDMS, Information, Tablet, Electronic, Global Investment in American Jobs Act of 2013, Mobile phone, Pet industry, Video game, Cryptocurrency, Semiconductor, Geography, Electronics

DUBLIN, Oct. 9, 2023 /PRNewswire/ -- The "3D TSV Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 9, 2023 /PRNewswire/ -- The "3D TSV Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The global market for 3D TSV Devices estimated at US$5.9 Billion in the year 2022, is projected to reach a revised size of US$27.7 Billion by 2030, growing at a CAGR of 21.3% over the analysis period 2022-2030.
  • Memory, one of the segments analyzed in the report, is projected to record 20.7% CAGR and reach US$8 Billion by the end of the analysis period.
  • The 3D TSV Devices market in the U.S. is estimated at US$954.3 Million in the year 2022.

IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

Retrieved on: 
Tuesday, October 3, 2023
Vaccine, Society, IO, Society for Immunotherapy of Cancer, SITC, Immunotherapy, PDT, Cell, Arginase, Location, Tumor microenvironment, Communications satellite

The third poster contains new pre-clinical data for the next candidate in the IO Biotech pipeline, IO112, which targets Arginase 1.

Key Points: 
  • The third poster contains new pre-clinical data for the next candidate in the IO Biotech pipeline, IO112, which targets Arginase 1.
  • Location and time: Poster Hall: 9:00 a.m.– 7:00 p.m. PDT; Poster session Lunch 12:00 –1.30 p.m.; Poster reception 5:10 – 6:40 p.m.
  • Location and time: Poster Hall: 9:00 a.m.– 8.30 p.m. PDT; Poster session lunch 11:55 a.m. – 1:25 p.m.; Poster reception 7:00 – 8.30 p.m.
  • Title: Arginase-1 vaccine promotes T cell immunity against arginase 1+ cells, controls tumor growth via immune modulation of tumor microenvironment
    Location and time: Poster Hall: 9 a.m.– 7 p.m. PDT; Poster session lunch 12:00 – 1.30 p.m.; Poster reception 5:10 – 6:40 p.m.

Advantest to Showcase Latest Semiconductor Test Solutions at the International Test Conference in Anaheim, California

Retrieved on: 
Monday, October 2, 2023
LBIST, SLT, MBIST, Advantest, IO, ATE, ATS, DUT, ARTS, ICS, UCIe, DUT board, Test, ACS, SLM, Socs, SCAN, Diagnosis, ITC, Ecosystem, Conference, VI, TSE, Printed circuit board, Synopsys

TOKYO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its latest test solutions for advanced ICs at the 2023 International Test Conference (ITC) on Oct. 8-13 at the Disneyland Convention Center in Anaheim, California.

Key Points: 
  • TOKYO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its latest test solutions for advanced ICs at the 2023 International Test Conference (ITC) on Oct. 8-13 at the Disneyland Convention Center in Anaheim, California.
  • International Test Conference is the world’s premier conference dedicated to the electronic test of devices, boards and systems-covering the complete cycle from design verification, test, diagnosis, failure analysis and back to process and design improvement.
  • Advantest's product showcase in booth #217 will highlight the company’s broad portfolio, including ATE, device interface, System Level Test (SLT) and analytics solutions that add customer value to the evolving semiconductor value chain.
  • The seamless portability of the structural test patterns developed for ATE platform ( Advantest V93000 ) on to ATS 7038 will be featured as well.

OSE Immunotherapeutics Announces H1 2023 Results and Provides Corporate Update

Retrieved on: 
Wednesday, September 27, 2023
Oncology, Health, Clinical Trials, Research, Science, Biotechnology, GDI Integrated Facility Services, Failure, DSMB, Data science, I&I, Head, Teaching hospital, Patent, Patient, Artificial intelligence, Kidney transplantation, OSE, Real, Physician, Lung cancer, EMA, Boehringer Ingelheim, RNA therapeutics, Lymphoma, Interleukin 7, FDA, Pancreatic cancer, AACR, International, ICI, United States Patent and Trademark Office, Cancer, Hook effect, Biomarker, Immunotherapy, Antibody, Ulcerative colitis, Transplant, Therapy, Partnership, CD28, IBD, IO, RNA, ASCO, American Society of Clinical Oncology, First, ISIN, Poster, AI, Society, Pharmaceutical industry, Vaccine, Medical imaging, Fine chemical, NSCLC

OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announces its consolidated half-year financial results and provides updates on key milestones achieved during H1 2023 as well as the Company’s outlook for its immunotherapies in immuno-oncology and immuno-inflammation.

Key Points: 
  • OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announces its consolidated half-year financial results and provides updates on key milestones achieved during H1 2023 as well as the Company’s outlook for its immunotherapies in immuno-oncology and immuno-inflammation.
  • Eric Leire was appointed independent Director of OSE Immunotherapeutics on June 22, 2023.
  • Nicolas Poirier, Chief Executive Officer of OSE Immunotherapeutics, was appointed as Director and Anne-Laure Autret-Cornet, Chief Financial Officer, as Director representing the employee shareholders.
  • The key figures of the 2023 consolidated half-year results are reported below:

INTEGRATED ONCOLOGY NETWORK WELCOMES NEW CHIEF INFORMATION TECHNOLOGY OFFICER

Retrieved on: 
Wednesday, September 27, 2023
Artificial intelligence, Society for Integrative Oncology, Health, Patient, IO, Retail, Nursing, Management

NASHVILLE, Tenn., Sept. 27, 2023 /PRNewswire/ -- Integrated Oncology Network (IO Network) is excited to announce the appointment of William Figueroa, a seasoned industry expert, as our new Chief Information Technology Officer. With a track record of transformative leadership in healthcare technology, Figueroa will spearhead our efforts to integrate cutting-edge technology, streamline operations, and enhance patient care across our extensive network of community-based clinics.

Key Points: 
  • NASHVILLE, Tenn., Sept. 27, 2023 /PRNewswire/ -- Integrated Oncology Network (IO Network) is excited to announce the appointment of William Figueroa, a seasoned industry expert, as our new Chief Information Technology Officer.
  • With a track record of transformative leadership in healthcare technology, Figueroa will spearhead our efforts to integrate cutting-edge technology, streamline operations, and enhance patient care across our extensive network of community-based clinics.
  • Integrated Oncology Network is committed to embracing forward-thinking leadership, embodying a dedication to staying at the forefront of healthcare advancements.
  • The appointment of William Figueroa as Chief Information Technology Officer reflects this commitment and sets the stage for an exciting new chapter in our journey towards integrating technology and healthcare to improve the lives of those we serve.

Winbond Introduces Innovative CUBE Architecture for Powerful Edge AI Devices

Retrieved on: 
Wednesday, September 27, 2023
High, Cow, Winbond, TSV, 3D, Electronics, SOC, World of Warcraft, Architecture, ADAS, Video game, Computer data storage, IO, AI

The technology is suited to advanced applications such as wearable and edge server devices, surveillance equipment, ADAS, and co-robots

Key Points: 
  • The technology is suited to advanced applications such as wearable and edge server devices, surveillance equipment, ADAS, and co-robots
    "The CUBE architecture enables a paradigm shift in AI deployment," says Winbond.
  • "We believe that the integration of cloud AI and powerful edge AI will define the next phase of AI development.
  • With CUBE, we are unlocking new possibilities and paving the way for improved memory performance and cost optimization on powerful Edge AI device."
  • This not only enhances cost advantages, but also contributes to the overall efficiency, including small form factor of Edge AI devices.

FPT and Silvaco Ink Deal, Advancing Semiconductor Workforce and Business Expansion

Retrieved on: 
Friday, September 22, 2023
Education, Semiconductor, IOT (Internet of Things), Technology, Telecommunications, Software, Training, FPT, Workforce, Partnership, IO, EDA, TCAD, FPT University, Multimedia, IP, USD, Government, FPT Corporation, Investment, Video game

FPT Semiconductor, a subsidiary of FPT Corporation (FPT), today announced its partnership with Silvaco, US-based leading provider of TCAD, EDA software, and Design IP, aiming at fostering workforce and business growth in the semiconductor sector.

Key Points: 
  • FPT Semiconductor, a subsidiary of FPT Corporation (FPT), today announced its partnership with Silvaco, US-based leading provider of TCAD, EDA software, and Design IP, aiming at fostering workforce and business growth in the semiconductor sector.
  • Tapping into its partner’s customer base, FPT Semiconductor will provide IP on Silvaco's platform and become the exclusive representative and distributor of Silvaco's semiconductor software solutions in Vietnam.
  • In turn, Silvaco will become a strategic investor of FPT Semiconductor.
  • Here, he advocated collaborative efforts and called for government support from Vietnam and the United States to bolster semiconductor workforce development.

Oracle Releases Java 21 and Extends Support Roadmap

Retrieved on: 
Tuesday, September 19, 2023
Cloud, Foreign function interface, JCP, Generics in Java, ZGC, OpenJDK, Dynamic loading, Library, Memory, JDK Enhancement Proposal, Maintenance, Java version history, Java Community Process, JMS, Language, Organization, Java Native Interface, Triage, Growth, Safety, GraalVM, Virtual threads, API, Java Development Kit, Garbage, Java Platform, Standard Edition, Drew University, CPU, Java virtual machine, Java (software platform), JDK, JVM, IO, RedMonk, Writing, JEP, LAS, JUnit, Student, Oracle Cloud, Confusion, IDE, OCI, Structured concurrency, Amber, Video game, Satellite navigation device, Computer data storage, Coffee, Oracle

LAS VEGAS, Sept. 19, 2023 /PRNewswire/ -- Oracle CloudWorld -- Oracle today announced the availability of Java 21, the latest version of the world's number one programming language and development platform. Java 21 (Oracle JDK 21) delivers thousands of performance, stability, and security improvements, including platform enhancements that will help developers increase productivity and drive innovation and growth across their organizations. Oracle is showcasing the latest capabilities in Java 21 at Oracle CloudWorld, which takes place this week (September 18-21) in Las Vegas, NV and online at oracle.com/cloudworld. 

Key Points: 
  • Oracle will offer long term support for Java 21 for at least eight years.
  • Based on customer feedback and use in the Java ecosystem, Oracle has also announced that long term support for Java 11 has been extended through at least January 2032, providing at least eight more years of support and updates from Oracle.
  • The Java 21 release is the result of extensive collaboration between Oracle engineers and other members of the worldwide Java developer community via OpenJDK and the Java Community Process (JCP).
  • For more details on the features in Java 21, please read the Java 21 technical blog post .